Radiopharm Theranostics Ltd (RAD) — Strategic Asset Allocation Index
Radiopharm Theranostics Ltd (RAD) has a Strategic Asset Allocation Index of 0.1% as of December 2025. Strategic assets (PP&E of AU$49.77K plus long-term investments of AU$-) total AU$49.77K, measured against net assets of AU$49.94 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See RAD equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Radiopharm Theranostics Ltd Strategic Asset Allocation Index (2022–2025)
This chart shows how Radiopharm Theranostics Ltd's Strategic Asset Allocation Index has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the index stands at 0.1%, representing strategic assets of AU$49.77K against net assets of AU$49.94 Million AUD. For live market cap and overall valuation, see Radiopharm Theranostics Ltd market cap and net worth.
Annual Strategic Asset Allocation Index for Radiopharm Theranostics Ltd (2022–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Radiopharm Theranostics Ltd from 2022 to 2025, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Radiopharm Theranostics Ltd's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (AUD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.1% | AU$53.47K | AU$53.47K | AU$0.00 | AU$42.87 Million | ▼ -0.2 pp |
| 2024 | 0.4% | AU$100.80K | AU$60.80K | AU$40.00K | AU$27.35 Million | ▲ +0.2 pp |
| 2023 | 0.1% | AU$68.33K | AU$68.33K | AU$- | AU$45.58 Million | ▲ +0.1 pp |
| 2022 | 0.0% | AU$1.58K | AU$1.58K | AU$- | AU$62.96 Million | — |